Clinical trial

Nephropathy In Type 2 Diabetes and Cardio-renal Events

NCT00535925

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-10-01

PhasePHASE4

Study timeline

Study start (actual)2005-10-01Date precision: month

Registry last updated2020-08-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Nephropathyunresolved

Interventions

SoC therapyDRUG

irbesartanDRUG · verified · RxNorm: irbesartan

ramiprilDRUG · verified · RxNorm: ramipril

hydrochlorothiazideDRUG · verified · RxNorm: hydrochlorothiazide

furosemideDRUG · verified · RxNorm: furosemide

amlodipineDRUG · verified · RxNorm: amlodipine

atenololDRUG · verified · RxNorm: atenolol

doxazosinDRUG · verified · RxNorm: doxazosin

clonidineDRUG · verified · RxNorm: clonidine

simvastatinDRUG · verified · RxNorm: simvastatin

erythropoietinDRUG

aspirinDRUG · verified · RxNorm: aspirin

Sponsors & collaborators

University of Campania Luigi Vanvitellilead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00535925 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.